Dental Anaesthesia
Pharmavax AS is involved in clinical research focused on local anaesthesia for dental procedures, with interest in improving pain control during routine oral care and other chairside interventions.
- Local anaesthetic efficacy
- Oral pain management
- Dental procedural comfort
The sponsor’s research activity centres on comparing anaesthetic approaches used in dentistry, with attention to patient response in the setting of lidocaine-based anaesthesia.
Analgesic Combination Therapy
The company’s clinical interest includes the use of combined local anaesthetic agents to assess whether pairing compounds can enhance analgesic performance in dental settings.
- Lidocaine-prilocaine combination
- Comparative analgesia
- Peripheral pain blockade
This area reflects a focus on refining anaesthetic options for procedures requiring brief but effective pain suppression.
Genetic Pain Sensitivity
Pharmavax AS also explores anaesthetic response in participants with MC1R mutation, indicating interest in how inherited traits may influence pain perception and response to dental anaesthesia.
- Genotype-related analgesic response
- Pain sensitivity variation
- Personalised dental anaesthesia
Its research activity touches on the relationship between genetic variation and the effectiveness of local pain relief in oral procedures.
